Robugen

What Robugen does

Robugen GmbH & Co. KG Pharmazeutische Fabrik is a privately held German pharmaceutical manufacturer founded in 1927 and headquartered in Esslingen am Neckar, operating across three generations of family stewardship. The company produces over-the-counter (OTC) medicines in two technological modalities: synthetic small-molecule drugs with clearly defined active ingredient specifications, and plant-based (phytopharmaceutical) preparations derived from controlled-cultivation raw materials — including proprietary chamomile grown in Thuringia under the KIA (Kontrollierter Anbau) protocol. Robugen controls the entire production chain end-to-end at its single Esslingen facility, from development and formulation through manufacturing, in-house analytical testing, and batch release, with no evidence of contract manufacturing or external production outsourcing.

The commercial product portfolio spans four therapeutic verticals with nine established brands: cardiovascular and circulatory health (KORODIN Herz-Kreislauf-Tropfen, Antihydral Salbe), skin and dermatology (JOD WUNDSALBE with povidone-iodine, VIRUDERMIN Gel for herpes labialis, HAMASANA Hamamelis Salbe, KAMILLIN EXTERN chamomile extract), respiratory and cold care (TUMAROL N Balsam, LARYLIN Hustenstiller Pastillen), and digestive health (ILIO FUNKTON Kautabletten with simeticon). Each product is offered in multiple pack sizes with assigned PZN numbers. Notable technical differentiators include a PA-free (pyrrolizidine alkaloid-free) chamomile extract that is batch-tested against all 28 relevant PAs to meet BfArM and HMPC requirements, and product-specific efficacy claims (e.g., KORODIN producing measurable blood pressure increase within 1–5 minutes; JOD WUNDSALBE eliminating 99.9% of relevant pathogens within 30 seconds).

The business model is a one-time sale of finished OTC pharmaceutical units distributed exclusively through the German pharmacy (Apotheken) channel, with no direct-to-consumer e-commerce, no export operations documented, and no B2B or institutional customers identified. Marketing is conducted through pharmacy-network partnerships and professional medical information (Fachinformationen) targeting physicians and pharmacists, supported by an "Apothekenfinder" tool integrated with Apotheken Umschau. At least one product (JOD WUNDSALBE) is GKV-verschreibungsfähig mit Festbetrag (reimbursable under statutory health insurance at a fixed price), while the broader portfolio is sold prescription-free. The company is led by Managing Directors Dr. rer. nat. Matthias Mauz and Stefan Eberspächer; revenue, headcount, and detailed financial data are not publicly disclosed.

Name

Robugen

Legal name

Robugen GmbH & Co. KG

Website

https://robugen.de

Company type

Private

Founded year

1927

Operating status

Operating

Headcount range

1–10 employees

Short description

Robugen is a family-owned German pharmaceutical manufacturer founded in 1927 that produces OTC medicines across cardiovascular, skin, respiratory, and digestive therapeutic areas. It controls end-to-end production at its Esslingen facility from synthetic and phytopharmaceutical raw materials, distributing exclusively through German pharmacies.

Ownership category

akta.pro rank

Product category

Over-the-Counter Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Medicinal and Botanical Manufacturing (325411)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

akta.pro secondary industries

Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity) (HLAIAAAE), Cold, Flu & Cough Remedies (HLAIADAB), Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal) (CRADAMAF)

Keywords

• Over-the-counter pharmaceuticals
• Phytopharmaceutical medicines
• OTC drug manufacturing
• Herbal medicinal products
• German pharmaceutical factory

Headquarters

HQ city

Esslingen

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical product sales: Robugen generates revenue through the manufacture and sale of over-the-counter (OTC) pharmaceutical products. Products are sold through pharmacies in Germany. The company offers multiple pack sizes for each product (e.g., JOD WUNDSALBE 15g, KORODIN in 10ml/40ml/100ml, ILIO FUNKTON in 20/50/10x20 tablets).

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Robugen GmbH Pharmazeutische Fabrik manufactures and sells over-the-counter (OTC) pharmaceutical products — including plant-based and synthetic medicines — across four therapeutic areas (cardiovascular, skin, respiratory, digestive). All production, testing, and batch release is controlled in-house at the Esslingen facility, and finished products are distributed prescription-free (rezeptfrei) exclusively through pharmacies in Germany under established brand names such as KORODIN, JOD WUNDSALBE, VIRUDERMIN, LARYLIN, TUMAROL, KAMILLIN, HAMASANA, ILIO FUNKTON, and Antihydral.

Product overview

Robugen GmbH Pharmazeutische Fabrik is a German pharmaceutical manufacturer founded in 1927, specializing in over-the-counter (OTC) and prescription medications. The company operates an integrated production model at its Esslingen facility, controlling everything from development to batch release in-house. Their product portfolio spans four therapeutic areas: (1) Cardiovascular/ Circulation products including KORODIN Herz-Kreislauf-Tropfen and Antihydral Salbe; (2) Skin/Dermatology products including JOD WUNDSALBE Robugen (antiseptic ointment), VIRUDERMINGel (cold sore treatment), HAMASANA Hamamelis Salbe, and KAMILLIN EXTERN ROBUGEN (chamomile extract); (3) Respiratory/Cold products including TUMAROL N Balsam and LARYLIN Hustenstiller Pastillen; and (4) Gastrointestinal products including ILIO FUNKTON Kautabletten. Robugen develops both synthetic and plant-based (phytopharmaceutical) drugs, with proprietary cultivation of chamomile in Thuringia for their herbal preparations.

Differentiator

Problem solved

Functional benefit

Brands

• Antihydral: Topical ointment product for excessive sweating.
• Korodin Herz-Kreislauf-Tropfen
• Hamasana Hamamelis Salbe
• Kamillin Extern Robugen
• Larylin Hustenstiller
• Ilio Funkton Kautabletten
• Tumarol N Balsam
• Virudermin Gel
• Jod Wundsalbe Robugen

Products and services

• KORODIN Herz-Kreislauf-Tropfen Plant-based medicinal product (drops) containing natural D-camphor and hawthorn fruit fluidextract, marketed for circulatory support in patients experiencing dizziness from low blood pressure, particularly upon standing after lying, bending, or prolonged sitting (hypotonic and orthostatic circulatory regulation disorders).
• JOD WUNDSALBE Robugen Antiseptic ointment for skin and wounds containing 10% povidone-iodine; used for initial treatment of small superficial wounds and mild burns, and for chronic wounds such as pressure ulcers and lower leg ulcers.
• VIRUDERMIN Gel Astringent gel containing zinc sulfate for early treatment of cold sores (Herpes labialis); claimed to inhibit virus replication, dry affected areas, and relieve pain when applied at first signs of tingling or tension.
• TUMAROL N Balsam Herbal balm containing eucalyptus oil, D-camphor, and levomenthol; applied by rubbing, the essential oils are absorbed through the skin and reach the respiratory tract via body heat, intended to provide freer breathing, loosen mucus, and relieve coughs, colds, and hoarseness.
• ILIO FUNKTON Kautabletten Chewable tablets containing simeticon 85mg (equivalent to 80mg dimeticon) that physically dissolve excess gas in the gastrointestinal tract; well-tolerated with no known drug interactions, and suitable for use during pregnancy and lactation.
• LARYLIN Hustenstiller Pastillen Cough suppressant lozenges containing dropropizin that relieve dry, tickly cough and spasmodic coughing by targeting binding sites in the respiratory tract; gluten-free and alcohol-free.
• KAMILLIN EXTERN ROBUGEN High-quality chamomile flower extract for external use as an additive for baths, compresses, and rinses, with anti-inflammatory and skin-regenerating properties; made from controlled-cultivation chamomile flowers from Thuringia, with each batch tested for all 28 relevant pyrrolizidine alkaloids (PA-free).
• HAMASANA Hamamelis Salbe Nourishing ointment with natural extract from bark and leaves of virginian witch hazel (Hamamelis virginiana); protects against drying out, nourishes cracked and brittle skin, and helps with skin fissures.
• Antihydral Salbe Topical pharmaceutical ointment from Robugen's product portfolio, categorized by the company as a cardiovascular/skin therapeutic product.

Quantifiable outcome

• KORODIN demonstrates measurable blood pressure increase within 1-5 minutes
• +1 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators1 record

Recent moves1 record

Expansion highlights4 records

Direct peers

• Pascoe pharmazeutische Präparate GmbH: German family-owned pharmaceutical manufacturer specializing in phytopharmaceutical and homeopathic OTC products. Comparable to Robugen in scale, therapeutic categories (cough, cold, circulatory), and German pharmacy channel focus.
• STADA Arzneimittel AG: Major German-headquartered manufacturer of generics and OTC pharmaceuticals, distributing through European pharmacies. Closely comparable to Robugen as a regulated, Germany-based OTC producer with multi-category consumer health exposure.
• Hevert Arzneimittel GmbH & Co. KG: German family-owned manufacturer of homeopathic and phytopharmaceutical OTC products distributed through pharmacies. Comparable to Robugen in size, family-ownership structure, and multi-therapeutic phytopharmaceutical portfolio.
• Bionorica SE: German phytopharmaceutical manufacturer specializing in plant-based OTC medicines for respiratory, urinary, and gynecological indications. Comparable to Robugen through the phytopharmaceutical platform and European pharmacy distribution model.
• Dermapharm Holding SE: German OTC and generic pharmaceutical manufacturer focused on branded healthcare products sold through pharmacies. Directly comparable in scale and channel strategy to Robugen's pharmacy-distributed OTC model.
• Dr. Willmar Schwabe GmbH & Co. KG: German family-owned phytopharmaceutical company producing plant-based medicines for cough, cold, cardiovascular, and other indications. Highly comparable to Robugen given the shared plant-based platform, German heritage, and OTC pharmacy distribution.
• Klosterfrau Berlin GmbH: German manufacturer of herbal and traditional OTC medicines including Klosterfrau Melissengeist and related pharmacy-distributed brands. Closely comparable to Robugen in herbal/OTC positioning and German pharmacy distribution.

Broad incumbents

• Bayer AG (Consumer Health Division): Global pharmaceutical giant with a Consumer Health division covering OTC products in cardiovascular, dermatology, respiratory, and digestive categories. Comparable to Robugen as a broader incumbent in the same OTC therapeutic areas, though at vastly larger scale.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/robugen-gmbh-pharmazeutische-fabrik

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Robugen